Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiajun Wang

Showing results (511-520 of 541) with videos related to

Pageof 55
Sort By:
Nature Communications|March 6, 2014
Size-dependent surface phase change of lithium iron phosphate during carbon coatingJiajun Wang, Jinli Yang, Yongji Tang, et al.
Materials Today. Bio|September 24, 2024
Photothermal and host immune activated therapy of cutaneous tuberculosis using macrophage targeted mesoporous polydopamine nanoparticlesShuhao Fan, Daina Zhao, Jiajun Wang, et al.
Oncoimmunology|January 18, 2021
Identification and validation of poor prognosis immunoevasive subtype of muscle-invasive bladder cancer with tumor-infiltrating podoplanin<sup>+</sup> cell abundanceQuan Zhou, Zewei Wang, Han Zeng, et al.
Journal for Immunotherapy of Cancer|June 17, 2020
Stromal LAG-3<sup>+</sup> cells infiltration defines poor prognosis subtype muscle-invasive bladder cancer with immunoevasive contextureHan Zeng, Quan Zhou, Zewei Wang, et al.
Iscience|June 17, 2026
Prevalence of ARGs in poultry-associated <i>E. coli</i> in Zhejiang Province, China: A genotypic surveyAfeng Wang, Liu Xu, Yuliang Sun, et al.
International Immunopharmacology|October 25, 2025
Exosomal co-delivery of CircRNA-TRAPPC6B and rifampicin for enhanced immunotherapy against tuberculosisJiang Pi, Yuhe Ma, Wandang Wang, et al.
Oncoimmunology|November 12, 2020
Tumor-infiltrating TNFRSF9<sup>+</sup> CD8<sup>+</sup> T cells define different subsets of clear cell renal cell carcinoma with prognosis and immunotherapeutic responseYaohui Li, Zewei Wang, Wenbin Jiang, et al.
Cancer Research|February 16, 2020
Blockade of DC-SIGN<sup>+</sup> Tumor-Associated Macrophages Reactivates Antitumor Immunity and Improves Immunotherapy in Muscle-Invasive Bladder CancerBaoying Hu, Zewei Wang, Han Zeng, et al.
Journal for Immunotherapy of Cancer|February 16, 2021
Intratumoral CXCL13<sup>+</sup>CD8<sup>+</sup>T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinomaSiyuan Dai, Han Zeng, Zhaopei Liu, et al.
Oncoimmunology|April 22, 2020
Tumor-infiltrating IL-17A<sup>+</sup> cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancerZewei Wang, Quan Zhou, Han Zeng, et al.
Pageof 55

Showing results (511-520 of 541) with videos related to

Sort By:
Pageof 55
Nature Communications|March 6, 2014
Size-dependent surface phase change of lithium iron phosphate during carbon coatingJiajun Wang, Jinli Yang, Yongji Tang, et al.
Materials Today. Bio|September 24, 2024
Photothermal and host immune activated therapy of cutaneous tuberculosis using macrophage targeted mesoporous polydopamine nanoparticlesShuhao Fan, Daina Zhao, Jiajun Wang, et al.
Oncoimmunology|January 18, 2021
Identification and validation of poor prognosis immunoevasive subtype of muscle-invasive bladder cancer with tumor-infiltrating podoplanin<sup>+</sup> cell abundanceQuan Zhou, Zewei Wang, Han Zeng, et al.
Journal for Immunotherapy of Cancer|June 17, 2020
Stromal LAG-3<sup>+</sup> cells infiltration defines poor prognosis subtype muscle-invasive bladder cancer with immunoevasive contextureHan Zeng, Quan Zhou, Zewei Wang, et al.
Iscience|June 17, 2026
Prevalence of ARGs in poultry-associated <i>E. coli</i> in Zhejiang Province, China: A genotypic surveyAfeng Wang, Liu Xu, Yuliang Sun, et al.
International Immunopharmacology|October 25, 2025
Exosomal co-delivery of CircRNA-TRAPPC6B and rifampicin for enhanced immunotherapy against tuberculosisJiang Pi, Yuhe Ma, Wandang Wang, et al.
Oncoimmunology|November 12, 2020
Tumor-infiltrating TNFRSF9<sup>+</sup> CD8<sup>+</sup> T cells define different subsets of clear cell renal cell carcinoma with prognosis and immunotherapeutic responseYaohui Li, Zewei Wang, Wenbin Jiang, et al.
Cancer Research|February 16, 2020
Blockade of DC-SIGN<sup>+</sup> Tumor-Associated Macrophages Reactivates Antitumor Immunity and Improves Immunotherapy in Muscle-Invasive Bladder CancerBaoying Hu, Zewei Wang, Han Zeng, et al.
Journal for Immunotherapy of Cancer|February 16, 2021
Intratumoral CXCL13<sup>+</sup>CD8<sup>+</sup>T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinomaSiyuan Dai, Han Zeng, Zhaopei Liu, et al.
Oncoimmunology|April 22, 2020
Tumor-infiltrating IL-17A<sup>+</sup> cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancerZewei Wang, Quan Zhou, Han Zeng, et al.
Pageof 55